Heidi Wang

Company: OBI Pharma USA

Job title: Chief Executive Officer

Seminars:

Navigating Varying Regulatory Guidance to Inform ADC Clinical Studies & Meet Global Regulatory Requirements 9:03 am

The biggest roadblock in developing ADCs in Asia is not having enough regulatory guidance from other agencies. This is especially important when trying to run clinical trials in multiple countries while adhering to varying regulatory guidelines. This interactive session will give you a holistic overview of varying government regulations and how to follow them to…Read more

day: Pre-Conference Workshop Day

Exploring the OBI Pharma ADC Assets & the GlycOBI™ Platform 2:30 pm

Discover how OBI Pharma has developed a unique glycan ADC platform (GlycOBI™) to enable a site-specific conjugation, which is in a ‘Plug and Play’ format and compatible with any antibodies, linkers, and payloads in various DAR Review how assets using the GlycOBI™ platform have the potential for improved in vivo efficacy, better safety profile, and…Read more

day: Day One